financetom
Business
financetom
/
Business
/
Pearl Energy-backed Infinity Natural valued at $1.3 billion as shares jump in NYSE debut
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pearl Energy-backed Infinity Natural valued at $1.3 billion as shares jump in NYSE debut
Jan 31, 2025 9:48 AM

(Reuters) -Private equity-backed Infinity Natural Resources ( INR ) was valued at $1.30 billion after shares of the oil and natural gas producer rose 10.8% in their debut on the New York Stock Exchange on Friday.

The Morgantown, West Virginia-based company's stock opened at $22.16, above the offer price of $20 apiece.

Infinity, backed by buyout firms Pearl Energy Investments and NGP, sold 13.25 million shares within the marketed range of $18 and $21 to raise $265 million.

The listing comes against the backdrop of a more fossil fuel-friendly Trump administration amid a steady stream of energy IPOs.

President Donald Trump last week declared a national energy emergency to boost U.S. oil and natural gas production.

Founded in 2017, Infinity has grown over the years through a series of acquisitions. Its operations are located in the Appalachian basin in the northeastern United States.

The company, which has amassed about 93,000 net acres, goes public after more than doubling its profit in the first nine months of 2024.

Infinity has exposure to both oil and gas assets, allowing it the flexibility to shift its drilling efforts based on commodity price changes.

Its major customers include Marathon Oil, BP America and Blue Racer Midstream. The company acquired certain oil and gas assets from Utica Resource Ventures and PEO Ohio for $279 million last year.

Citigroup, Raymond James and RBC Capital Markets were the lead underwriters for the offering.

Pearl and NGP continue to collectively hold a majority of Infinity's voting power.

The company, which tapped 14 banks for the offering, will use the proceeds to repay debt and for other purposes.

Marine transportation services provider Hornbeck Offshore Services and drilling equipment provider HMH Holding are among the other IPO hopefuls from the energy sector.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Microsoft Delivers Another Strong Quarter with Impressive Results, Wedbush Says
Microsoft Delivers Another Strong Quarter with Impressive Results, Wedbush Says
Apr 26, 2024
12:30 PM EDT, 04/26/2024 (MT Newswires) -- Microsoft ( MSFT ) latest Q3 results showcased yet another strong quarter with impressive outcomes across the board, Wedbush said in a report Friday. Microsoft Azure's growth soared at 31%, surpassing both the Wall Street's estimate of 29% and the company's own guidance of 28%, driven by strong demand for their updated tech...
Royal Caribbean, Seminole Gaming, Hard Rock Combining Rewards Programs in New Partnership
Royal Caribbean, Seminole Gaming, Hard Rock Combining Rewards Programs in New Partnership
Apr 26, 2024
12:27 PM EDT, 04/26/2024 (MT Newswires) -- Royal Caribbean Group (RCL) on Friday announced a new partnership allowing travelers on the cruise line's ships to book discounted rooms, meals and other benefits at Hard Rock International and Seminole Gaming locations by combining the three companies' respective rewards programs. The reciprocal agreement extends to Hard Rock and Seminole Gaming guests using...
Chemed Reports 'Soft' Q1 as Roto-Rooter Continues to Face Pressure, Oppenheimer Says
Chemed Reports 'Soft' Q1 as Roto-Rooter Continues to Face Pressure, Oppenheimer Says
Apr 26, 2024
12:35 PM EDT, 04/26/2024 (MT Newswires) -- Chemed's ( CHE ) Q1 results were a rare earnings miss as its Roto-Rooter unit continued to face pressure in the quarter coupled with ineffective returns on paid advertising, Oppenheimer said in a note Thursday. Chemed ( CHE ), however, continues to offer an attractive and stable investment opportunity, the research firm said....
Johnson & Johnson Says Europe's CHMP Recommends Approval of Rybrevant Plus Chemotherapy for Lung Cancer Treatment
Johnson & Johnson Says Europe's CHMP Recommends Approval of Rybrevant Plus Chemotherapy for Lung Cancer Treatment
Apr 26, 2024
12:29 PM EDT, 04/26/2024 (MT Newswires) -- Johnson & Johnson's ( JNJ ) Janssen-Cilag International said Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use, or CHMP, has recommended the approval of Rybrevant (amivantamab), in combination with chemotherapy for the treatment of adult patients with advanced non-small cell lung cancer. The recommendation is supported by the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved